- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-04-0004319

About Care Formulation Labs Private Limited
Data last updated:
Care Formulation Labs Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 25 November 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2010PTC210765. Its GSTIN is 07AAECC3106E1Z9 (Delhi). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Naveen Kumar Jindal and Pawan Kumar Jindal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at E – 673 Dsidc Narela Industrial Area, New Delhi, Delhi, India – 110040.
As per the financials filed for FY 2025, the company reported a revenue of ₹125.33 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹3.93 Cr (net margin 3.1%) and EBITDA of ₹7.46 Cr (EBITDA margin 5.9%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 24% over five years.
The company has about 18 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Care Formulation Labs. As per MCA filings, the company has open charges of ₹29.8 Cr and satisfied charges of ₹3.22 Cr on record. Court records list 29 cases involving the company, including 20 filed by the company and 9 filed against it; 8 cases are pending.
Care Formulation Labs Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-04-0004319). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website careformulationlabs.com.
Company details
Recognitions & Rankings of Care Formulation Labs
Contact details
Care Formulation Labs Private Limited's registered office is in New Delhi, Delhi. Its website is careformulationlabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressE – 673 Dsidc Narela Industrial Area, New Delhi, Delhi, India – 110040
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Care Formulation Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Care Formulation Labs operates one associated brand: Care Formulation Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Distributes pharmaceutical drugs and medical products across categories in India. | careformulationlabs.com |
Business activity
The main business activity of Care Formulation Labs is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Care Formulation Labs Private Limited, buy the company report.
Financials of Care Formulation Labs Private Limited
FY 2024 filings availableCare Formulation Labs Private Limited reported revenue of ₹125.33 Cr (up 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 19% growth in the latest year. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.46 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.93 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.9% | ||||
| Net Profit Margin | 3.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Care Formulation Labs Private Limited, buy the company report.
Board of directors of Care Formulation Labs Private Limited
Care Formulation Labs has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naveen Kumar Jindal Also directs: Ausmed Life Science LLP | Director | 25 Nov 2010 | 15 Years 10 Months | Current |
| Pawan Kumar Jindal Also directs: Ausmed Life Science LLP | Director | 25 Nov 2010 | 15 Years 10 Months | Current |
Peer comparison
Care Formulation Labs Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aiocd Pharma Limited | ₹127.15 Cr (FY 2025) | 17.0% | Mumbai, Maharashtra, India | |||
| Kyal Agencies Private Limited | ₹127.04 Cr (FY 2025) | 14.0% | Bhubaneswar, Odisha, India | |||
| Evolet Healthcare Private Limited | ₹126.91 Cr (FY 2025) | -5.0% | Bhorakalan, Haryana, India | |||
| Dhanvanthri Super Speciality Private Limited | ₹126.02 Cr (FY 2025) | 318.0% | Bangalore, Karnataka, India | |||
| Care Formulation Labs Private Limitedthis company | ₹125.33 Cr (FY 2025) | ₹3.93 Cr | 3.1% | 19.0% | 18 | New Delhi, Delhi, India |
| Jaggi Enterprises Private Limited | ₹123.9 Cr (FY 2025) | 8.0% | New Delhi, Delhi, India | |||
| Kaafi Enterprises Private Limited | ₹122.9 Cr (FY 2024) | 2.0% | Mumbai, Maharashtra, India | |||
| B M Chemie Private Limited | ₹121.23 Cr (FY 2025) | 2752.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Care Formulation Labs Private Limited, buy the company report.
Auditor
Care Formulation Labs Private Limited is audited by SSAR & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SSAR & ASSOCIATES | FY 2024 | 004739N |
Shareholding
The shareholding of Care Formulation Labs Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Care Formulation Labs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Jun 2025 | 101114488 | Others | ₹5 Cr | Open | |
| 30 Jan 2014 | 10478801 | Others | ₹24.8 Cr | Open | |
| 25 Jun 2024 | 100937464 | Others | ₹15 Lakh | Satisfied | |
| 29 Jun 2021 | 100458647 | Others | ₹1.99 Cr | Satisfied | |
| 01 Jun 2020 | 100348434 | Others | ₹58.59 Lakh | Satisfied |
To see the full charge records of Care Formulation Labs Private Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
Care Formulation Labs Private Limited has 29 court cases on record: 20 filed by Care Formulation Labs, 9 filed against it. 8 cases are pending and 21 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 26 | 7 | 6 |
| High courts | 3 | 2 | 2 |
Cases on record (5 of 29)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Modi-Mundipharma Pvt. Ltd. | Pending |
| High Court of Delhi | Commercial suit | Filed against the company by Zydus Wellness Products Ltd | Pending |
| District court, New Delhi, Delhi | Court case (CS (COMM.)) | Filed against the company by Wings Pharmaceuticals Pvt Ltd. | Disposed |
| District court, North, Delhi | Court case (CS (COMM.)) | Filed by the company against M/S. Ranjana Healthcare Pvt. Ltd. | Disposed |
| District court, Central, Delhi | Civil suit | Filed by the company against National Insurance Company Ltd. | Disposed |
To see the full case history of Care Formulation Labs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Care Formulation Labs Private Limited was last rated by Crisil on 23 Jul 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 23 Jul 2020 |
To see the full credit ratings and regulatory alerts of Care Formulation Labs Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Care Formulation Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Care Formulation Labs Private Limited has a workforce of 18 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
Care Formulation Labs has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECC3106E1Z9 | Delhi | Active | 01 Jul 2017 |
| 09AAECC3106E1Z5 | Uttar Pradesh | Active | 28 Sep 2017 |
| 06AAECC3106E1ZB | Haryana | Active | 08 Apr 2024 |
To see the full GST registrations and return filing status of Care Formulation Labs Private Limited, buy the company report.
Recent activity
Care Formulation Labs Private Limited has 3 board changes on record since 2010: 2 appointments and 1 cessation. The latest: Rajinder Kumar Jindal ceased to be Additional Director on 29 Sep 2018.
5 earlier events are in the company report.
Frequently asked questions
Care Formulation Labs is an active private limited company based in New Delhi, Delhi, India. The company works in wholesale, within the trading industry. It was incorporated on 25 November 2010 (16+ years old) and is registered under CIN U24100DL2010PTC210765.
Care Formulation Labs has 2 current directors:
- Naveen Kumar Jindal - Director
- Pawan Kumar Jindal - Director
The latest financial statements of Care Formulation Labs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Care Formulation Labs is 07AAECC3106E1Z9, registered in Delhi. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 09AAECC3106E1Z5 (Uttar Pradesh), 06AAECC3106E1ZB (Haryana).
The CIN (Corporate Identification Number) of Care Formulation Labs is U24100DL2010PTC210765. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Care Formulation Labs has 29 court cases on record: 20 filed by the company and 9 filed against it. 8 are pending. Most are in the district courts.
Care Formulation Labs was incorporated on 25 November 2010, making it 16+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Care Formulation Labs by revenue are Aiocd Pharma Limited, Kyal Agencies Private Limited, Evolet Healthcare Private Limited, Dhanvanthri Super Speciality Private Limited, Jaggi Enterprises Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Rajinder Kumar Jindal ceased to be Additional Director on 29 Sep 2018. Naveen Kumar Jindal was appointed as Director on 25 Nov 2010. Pawan Kumar Jindal was appointed as Director on 25 Nov 2010.
Yes, Care Formulation Labs is registered as a medium enterprise under Udyam registration (number: UDYAM-DL-04-0004319).
Care Formulation Labs can be reached through the website careformulationlabs.com. Its registered office is in New Delhi, Delhi, India.